Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis

Journal of Clinical Microbiology

Volumn 44, Issue 11, 2006, Pages 4136-4141

  Gophna, Uri ^a   Sommerfeld, Katrin ^b   Gophna, Sharon ^b,d   Doolittle, W Ford ^b   Veldhuyzen Van Zanten, Sander J O ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b DALHOUSIE UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; RNA 16S;

ADULT; ARTICLE; BACTERIUM COLONY; BACTEROIDETES; CLINICAL ARTICLE; CLONE; CLOSTRIDIUM; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DNA EXTRACTION; ENTERITIS; FEMALE; GASTROINTESTINAL BIOPSY; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE FLORA; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLASMID VECTOR; PRIORITY JOURNAL; PROTEOBACTERIA; SEQUENCE ANALYSIS; TAXONOMY; ULCERATIVE COLITIS;

ADULT; AGED; ARCHAEA; BACTERIA; BACTEROIDES; CLOSTRIDIUM; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INTESTINES; MALE; MIDDLE AGED; PROTEOBACTERIA;

BACTERIA (MICROORGANISMS); BACTEROIDETES; CLOSTRIDIA; PROTEOBACTERIA;

EID: 33750956239     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01004-06     Document Type: Article

References (28)

1. Barcenilla, A., S. E. Pryde, J. C. Martin, S. H. Duncan, C. S. Stewart, C. Henderson, and H. J. Flint. 2000. Phytogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 66:1654-1661.
2. Chao, A., R. L. Chazdon, R. K. Colwell, and T.-J. Shen. 2005. A new statistical approach for assessing similarity of species composition with incidence and abundance data. Ecol. Lett. 8:148-159.
3. Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson, and D. A. Relman. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638.
4. Eckburg, P. B., P. W. Lepp, and D. A. Relman. 2003. Archaea and their potential role in human disease. Infect. Immun. 71:591-596.
5. Franchimont, D., S. Vermeire, H. El Housni, M. Pierik, K. Van Steen, T. Gustot, E. Quertinmont, M. Abramowicz, A. Van Gossum, J. Deviere, and P. Rutgeerts. 2004. Deficient host-bacteria interactions in inflammatory bowel disease? The Toil-like receptor (TLR)-4 Asp299Gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53:987-992.
6. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, and P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869-8872.
7. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, S. J. Foster, A. P. Moran, J. L. Fernandez-Luna, and G. Nunez. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:5509-5512.
8. Kimura, M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
9. Kleessen, B., A. J. Kroesen, H. J. Buhr, and M. Blaut. 2002. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37:1034-1041.
10. Manichanh, C., L. Rigottier-Gois, E. Bonnaud, K. Gloux, E. Pelletier, L. Frangeul, R. Nalin, C. Jarrin, P. Chardon, P. Marteau, J. Roca, and J. Dore. 2006. Reduced diversity of faecal microbiula in Crohn's disease revealed by a metagenomic approach. Gut 55:205-211.
11. Marchesi, J. R., T. Sato, A. J. Weightman, T. A. Martin, J. C. Fry, S. J. Hiom, D. Dymock, and W. G. Wade. 1998. Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA. Appl. Environ. Microbiol. 64:795-799.
12. Ott, S. J., M. Musfeldt, D. F. Wenderoth, J. Hampe, O. Brant, U. R. Folsch, K. N. Timmis, and S. Schreiber. 2004. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53:685-693.
13. Prindiville, T. P., R. A. Sheikh, S. H. Cohen, Y. J. Tang, M. C. Cantrell, and J. Silva, Jr. 2000. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis. 6:171-174.
14. Pryde, S. E., S. H. Duncan, G. L. Hold, C. S. Stewart, and H. J. Flint. 2002. The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217:113-139.
15. Roediger, W. E. 1982. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83:424-429.
16. Sartor, R. B. 2001. Intestinal microflora in human and experimental inflammatory bowel disease. Curr. Opin. Gastroenterol. 17:324-330.
17. Schloss, P. D., and J. Handelsman. 2005. Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl. Environ. Microbiol. 71:1501-1506.
18. Schloss, P. D., B. R. Larget, and J. Handelsman. 2004. Integration of microbial ecology and statistics: a test to compare gene libraries. Appl. Environ. Microbiol. 70:5485-5492.
19. Segain, J. P., D. Raingeard de la Bletiere, A. Bourreille, V. Leray, N. Gervois, C. Rosales, L. Ferrier, C. Bonnet, H. M. Blottiere, and J. P. Galmiche. 2000. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47:397-403.
20. Seksik, P., P. Lepage, M. F. de la Cochetiere, A. Bourreille, M. Sutren, J. P. Galmiche, J. Dore, and P. Marteau. 2005. Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J. Clin. Microbiol. 43:4654-4658.
21. Seksik, P., L. Rigottier-Gois, G. Gramet, M. Sutren, P. Pochart, P. Marteau, R. Jian, and J. Dore. 2003. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52:237-242.
22. Swidsinski, A., A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54.
23. Tamboli, C. P., C. Neut, P. Desreumaux, and J. F. Colombel. 2004. Dysbiosis in inflammatory bowel disease. Gut 53:1-4.
24. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
25. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
26. Tiwana, H., R. S. Walmsley, C. Wilson, J. Y. Yiannakou, P. J. Ciclitira, A. J. Wakefield, and A. Ebringer. 1998. Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br. J. Rheumatol. 37:525-531.
27. Tiwana, H., C. Wilson, R. S. Walmsley, A. J. Wakefield, M. S. Smith, N. L. Cox, M. J. Hudson, and A. Ebringer. 1997. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatol. Int. 17:11-16.
28. Zoetendal, E. G., A. D. L. Akkermans, W. M. Akkermans-van Vliet, J. A. G. M. de Visser, and W. M. de Vos. 2001. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb. Ecol. Health Dis. 13:129-134.